News

Bringing together leaders from the supply side and the demand side of hospital digitalisation could be the key to a smoother transformation journey, as attendees at HIMSS22 Europe will find out. 

They will provide the first access to an AI-enabled minimal residual disease test in India.

The tech giant also announced a new atrial fibrillation history feature and sleep stage tracking.

Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.

If patients reported severe or worsening symptoms, their care teams were alerted.

Two variants of the Annalise CXR Edge products will be offered in Australia.

The AI solution has been trained based on a data set of 3.2 billion patient visits.

CEO Eren Bali said the company was winding down some of its COVID-19-related services and plans to shift its focus from growth to profitability.

Homeward CEO Dr. Jennifer Schneider discusses the startup's new partnership with Rite Aid, how their model works and why value-based care is paramount for rural communities.

Also, Standigm has partnered with Merck Korea for AI drug discovery research.